Brartemicin, an inhibitor of tumor cell invasion from the actinomycete Nonomuraea sp.

Yasuhiro Igarashi*, Tsukasa Mogi, Saeko Yanase, Satoshi Miyanaga, Tsuyoshi Fujita, Hiroaki Sakurai, Ikuo Saiki, Ayumi Ohsaki

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Abstract

Brartemicin (1), a new trehalose-derived metabolite, was isolated from the culture broth of the actinomycete of the genus Nonomuraea. Its structure and absolute configuration were determined by spectroscopic analyses. The new compound inhibited the invasion of murine colon carcinoma 26-L5 cells with an IC50 value of 0.39 μM in a concentration-dependent manner without showing cytotoxic effects.

Original languageEnglish
Pages (from-to)980-982
Number of pages3
JournalJournal of Natural Products
Volume72
Issue number5
DOIs
StatePublished - 2009/05/22

ASJC Scopus subject areas

  • Analytical Chemistry
  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science
  • Drug Discovery
  • Complementary and alternative medicine
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Brartemicin, an inhibitor of tumor cell invasion from the actinomycete Nonomuraea sp.'. Together they form a unique fingerprint.

Cite this